The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.

Amid the growing importance of pneumococcal vaccination to prevent pneumonia during the change of seasons, confusion is ...

Vaxcyte's new pneumococcal vaccine may only have phase 1/2 results behind it, but analysts are already predicting it could be a major competitor to rival shots from Pfizer and MSD. Just-reported ...

The rivalry between Pfizer and MSD in pneumococcal vaccines has dialled up a notch with the FDA approval of MSD’s new shot Capvaxive, the first to be aimed specifically at adults. The 21-valent ...

The Federal Republic of Somalia has introduced vaccines against pneumococcal infections and rotavirus diarrhoea into its national immunization programme. Pneumonia and diarrhoea-related illnesses are ...

For the first time, the US Centers for Disease Control and Prevention (CDC) is recommending pneumococcal vaccination for adults as young as 50, even if they are healthy. This guidance aligns with ...

Healthcare providers, public health officials and policymakers need to develop a greater understanding of the serious health impact of pneumococcal disease in elderly adults. In addition to ...

With half of hospital admissions for pneumonia affecting young and middle-aged adults, experts emphasize ...

Merck MRK announced that the European Commission (“EC”) has approved its 21-valent pneumococcal conjugate vaccine (“PCV”), Capvaxive, for the prevention of invasive pneumococcal disease ...

EC decision marks the fourth approval for CAPVAXIVE for pneumococcal vaccination in adults “Pneumococcal disease continues to pose a significant risk for adults in Europe, among adults who are ...

Apr. 9—(StatePoint) Pneumococcal pneumonia is a potentially serious bacterial lung disease that can disrupt your life for weeks and even land you in the hospital. Medical experts want you to ...